A UK digital health company has launched a secure mobile health platform with a much broader approach than the current offering. Existing solutions deliver for single conditions/one user/one language. This platform solution allows for multiple users and multiple languages at all times, which offers partners to think global on data studies.
The platform is patient-centric but approved by subject matter experts. Patients control their own data and can share relevant and specific data with those working to improve their health. The company has 15 conditions currently built but continues to expand its offering. The platform facilitates the easy capture, sharing and analysis of any relevant data points. Data is brought to life for the user via dashboards and graphs, allowing for a better understanding. The data is structured which lends itself to use in AI and scientific research.
The company are keen to work with medium-large companies with an interest in health. The current Australian trial will focus on a respiratory condition, but the company is working on a personalised healthcare approach which will facilitate all health conditions and co-morbidities. The company is keen to help validate joint programmes with any new partner via their new platform in collaboration with subject matter experts.
The type of co-operation may include a commercial agreement with technical assistance or a joint venture.